Key highlights Retatrutide is a peptide weight loss medication with a triple mechanism of action
Women ages 18 to 39 are the fastest-growing segment of people using GLP-1 drugs, growing from 7% to 14% among all U.S
As a no-needles alternative to GLP-1/GIP injections, or for maintenance post-GLP-1/GIP, this compounded formulation offers significant pros
While both are potent medications, they work in slightly different ways
Originally prescribed to treat people with type 2 diabetes, GLP-1 drugs are now being used to treat obesity and a variety of other medical conditions
The legal battles over Ozempics side effects bring to light critical questions about drug safety, transparency, and the responsibilities of pharmaceutical giants like Novo Nordisk